Clinical Trial Update: Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating interleukin-12 in combination with interferon alfa for metastatic melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interferon Alfa (interferon alfa)
• Interleukin-12 (interleukin-12)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Melanoma, Stage IV Melanoma | Phase 2 | Status: COMPLETED